Target Name: LOC100129455
NCBI ID: G100129455
Review Report on LOC100129455 Target / Biomarker Content of Review Report on LOC100129455 Target / Biomarker
LOC100129455
Other Name(s): Uncharacterized LOC100129455 | uncharacterized LOC100129455

LOC100129455: A Drug Target / Disease Biomarker

LOC100129455 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling.

LOC100129455 is characterized by its unique structure, which consists of a extracellular domain, a transmembrane segment, and an intracellular domain. The extracellular domain of LOC100129455 consists of a long amino acid sequence that is involved in the formation of a hydrophobic environment that can interact with other proteins. The transmembrane segment is composed of a single amino acid residue at its C-terminus, which is responsible for the formation of a hydrophilic environment that can interact with ligands on the intracellular side.

The intracellular domain of LOC100129455 is also characterized by a long amino acid sequence that is involved in the formation of a ion-poor environment that can interact with positively charged ions, such as calcium ions. This is important for the function of the protein, as it allows it to interact with other proteins and molecules that are important for cellular signaling.

LOC100129455 is expressed in a variety of tissues and organs, including the brain, heart, kidneys, and liver. It is highly expressed in the brain, where it is found in the postsynaptic density of neurons and glial cells. It is also expressed in the heart, where it is involved in the regulation of cardiac contractility and heart rate.

In addition to its expression in the brain and heart, LOC100129455 is also expressed in other organs and tissues. For example, it is highly expressed in the kidneys, where it is involved in the regulation of renal function and is thought to play a role in the development and progression of chronic kidney disease. It is also expressed in the liver, where it is involved in the regulation of metabolism and may be a potential drug target for a variety of diseases.

The unique structure of LOC100129455 makes it an attractive target for drug development. The protein is involved in a variety of cellular signaling pathways, and its function as a GPCR gene has been implicated in a wide range of diseases, including cardiovascular disease, neurodegenerative diseases, and chronic kidney disease.

In addition to its potential as a drug target, LOC100129455 is also a potential biomarker for a variety of diseases. The protein is highly expressed in a variety of tissues and organs, including the brain, heart, kidneys, and liver, which makes it a potential marker for a variety of diseases. For example, high levels of LOC100129455 have been associated with the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Overall, LOC100129455 is a protein that is highly expressed in various tissues and organs and is involved in a variety of cellular signaling pathways. Its unique structure and function make it an attractive target for drug development and a potential biomarker for a wide range of diseases. Further research is needed to fully understand the role of LOC100129455 in cellular signaling and its potential as a drug and biomarker.

Protein Name: Uncharacterized LOC100129455

The "LOC100129455 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100129455 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585